Axon Enterprise Inc. (AXON): Price and Financial Metrics
AXON Price/Volume Stats
| Current price | $731.37 | 52-week high | $748.80 |
| Prev. close | $723.75 | 52-week low | $273.52 |
| Day low | $714.00 | Volume | 422,600 |
| Day high | $735.43 | Avg. volume | 743,968 |
| 50-day MA | $603.79 | Dividend yield | N/A |
| 200-day MA | $538.26 | Market Cap | 56.94B |
AXON Stock Price Chart Interactive Chart >
Axon Enterprise Inc. (AXON) Company Bio
Axovant Sciences is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia, a condition characterized by significant decline in mental capacity and impaired daily function. The company was founded in 2014 and is based in Hamilton, Bermuda.
AXON Price Returns
| 1-mo | 23.82% |
| 3-mo | 42.51% |
| 6-mo | 18.15% |
| 1-year | 156.06% |
| 3-year | 665.51% |
| 5-year | N/A |
| YTD | 23.06% |
| 2024 | 130.06% |
| 2023 | 55.69% |
| 2022 | 5.69% |
| 2021 | 28.13% |
| 2020 | N/A |
Loading social stream, please wait...